About Prenosis
Prenosis is a biology-based technology company at the forefront of applying artificial intelligence and machine learning to revolutionize precision medicine in acute care. Their core mission is to move beyond a one-size-fits-all approach to healthcare by tailoring diagnostics and therapeutics to each patient’s unique biological profile. The company’s flagship product, Sepsis ImmunoScore®, is the first-ever FDA-authorized AI diagnostic tool for sepsis.
This innovative software as a medical device (AI SaMD) leverages a proprietary platform called Immunix™ to integrate deep biological data with extensive clinical data from a large biobank of over 100,000 blood samples and electronic medical records. The Sepsis ImmunoScore® analyzes up to 22 diverse parameters to holistically evaluate a patient’s biological status, providing a risk score and stratifying patients into four discrete risk categories for the presence of or progression to sepsis within 24 hours. This transparency in how the AI model calculates its score is crucial for building clinician trust and fostering a true clinician-AI partnership, enabling faster and more accurate treatment decisions, improved patient outcomes, and enhanced operational efficiency.
Beyond sepsis, Prenosis is expanding its focus to develop integrated diagnostic and therapeutic solutions for other critical acute care conditions. Their Immunix™ platform and evidence generation capabilities are being leveraged to create more diagnostic tools and AI-guided precision therapeutics for severe respiratory infections, including pneumonia and acute respiratory distress syndrome (ARDS), as well as exploring applications in heart failure and acute kidney injury.
What Physicians Need to Know
For physicians, Prenosis' Sepsis ImmunoScoreu2122 offers actionable, trustworthy insights for early and accurate sepsis detection, moving from a reactive to a proactive approach in patient care. It integrates directly into existing EMR systems, providing a sepsis risk score and stratifying patients into four discrete risk categories based on up to 22 parameters from the patient's record (demographics, vitals, labs, sepsis biomarkers). A key benefit is its transparency, revealing how individual patient parameters contribute to the score, fostering trust and enabling a true clinician-AI partnership. This tool aims to reduce alert fatigue associated with less precise early warning systems and supports clinical decision-making to improve patient outcomes, reduce hospital length of stay, and potentially decrease healthcare costs.
The Sepsis ImmunoScoreu2122 software is designed for direct integration into hospital Electronic Medical Records (EMRs), making it easily accessible within existing clinical workflows. It operates as a cloud-based system and utilizes the Aidbox FHIR Platform for an EHR-independent data store, ensuring robust security features, including HIPAA compliance and high availability.
What the Web Says
Prenosis is a health tech company that has developed the Sepsis ImmunoScore, an AI-powered diagnostic and predictive tool for early sepsis detection. The Sepsis ImmunoScore received FDA De Novo marketing authorization in 2024, making it the first AI diagnostic test for sepsis. The tool integrates with hospital EHRs, analyzes 22 health metrics, and provides a sepsis risk score to help clinicians diagnose infections and predict which patients are likely to progress to severe cases. While there is significant positive sentiment around the product's potential to save lives and improve patient outcomes, there is no readily available information on company/employer reviews for Prenosis specifically on the requested platforms.
Overall: MixedStrengths
- First FDA-authorized AI diagnostic tool for sepsis.
- High accuracy for sepsis diagnosis and prediction of adverse patient outcomes.
- Integrates with hospital EHRs for real-time information and timely interventions.
- Analyzes a comprehensive set of 22 biological and clinical parameters.
- Potential to reduce antibiotic overprescription and improve compliance with payer protocols.
- Transparent algorithmic methodology to build trust with clinicians.
Limitations
- No readily available company/employer reviews on G2, Glassdoor, Capterra, or Reddit.
- No specific product cons identified in the search results.
Last updated: 2026-07-20
Videos
News, demos, and interviews about Prenosis.
Videos load interactively. If none appear, search YouTube for Prenosis →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Prenosis.
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]